653 related articles for article (PubMed ID: 17461702)
1. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.
Parra D; Beckey NP; Stevens GR
Pharmacotherapy; 2007 May; 27(5):675-83. PubMed ID: 17461702
[TBL] [Abstract][Full Text] [Related]
2. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study.
Mahé I; Bertrand N; Drouet L; Bal Dit Sollier C; Simoneau G; Mazoyer E; Caulin C; Bergmann JF
Haematologica; 2006 Dec; 91(12):1621-7. PubMed ID: 17145598
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio.
Phillips EM; Buchan DA; Newman N; Rajan A; Zia S
Pharmacotherapy; 2005 Oct; 25(10):1341-7. PubMed ID: 16185178
[TBL] [Abstract][Full Text] [Related]
5. Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy.
Hughes GJ; Patel PN; Saxena N
Pharmacotherapy; 2011 Jun; 31(6):591-7. PubMed ID: 21923443
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol.
Heard K; Green JL; Bailey JE; Bogdan GM; Dart RC
Aliment Pharmacol Ther; 2007 Jul; 26(2):283-90. PubMed ID: 17593074
[TBL] [Abstract][Full Text] [Related]
7. Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trial.
Dentali F; Douketis JD; Woods K; Thabane L; Foster G; Holbrook A; Crowther M
Ann Pharmacother; 2006; 40(7-8):1241-7. PubMed ID: 16804099
[TBL] [Abstract][Full Text] [Related]
8. Moderate alcohol consumption and safety of lovastatin and warfarin among men: the post-coronary artery bypass graft trial.
Mukamal KJ; Smith CC; Karlamangla AS; Moore AA
Am J Med; 2006 May; 119(5):434-40. PubMed ID: 16651056
[TBL] [Abstract][Full Text] [Related]
9. Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.
Schulman S; Melinyshyn A; Ennis D; Rudd-Scott L
Thromb Res; 2010 May; 125(5):393-7. PubMed ID: 19640572
[TBL] [Abstract][Full Text] [Related]
10. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation.
Bianco TM; Bussey HI; Farnett LE; Linn WD; Roush MK; Wong YW
Pharmacotherapy; 1992; 12(6):435-9. PubMed ID: 1492006
[TBL] [Abstract][Full Text] [Related]
11. Search for predictors of nontherapeutic INR results with warfarin therapy.
McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
[TBL] [Abstract][Full Text] [Related]
12. The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial.
Ansell J; McDonough M; Zhao Y; Harmatz JS; Greenblatt DJ
J Clin Pharmacol; 2009 Jul; 49(7):824-30. PubMed ID: 19553405
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of empiric warfarin dose reduction with the initiation of doxycycline therapy.
Dowd MB; Kippes KA; Witt DM; Delate T; Martinez K
Thromb Res; 2012 Aug; 130(2):152-6. PubMed ID: 22221937
[TBL] [Abstract][Full Text] [Related]
14. Interaction between gemfibrozil and warfarin: case report and review of the literature.
Dixon DL; Williams VG
Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
16. Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial.
Zhang Q; Bal-dit-Sollier C; Drouet L; Simoneau G; Alvarez JC; Pruvot S; Aubourg R; Berge N; Bergmann JF; Mouly S; Mahé I
Eur J Clin Pharmacol; 2011 Mar; 67(3):309-14. PubMed ID: 21191575
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
Mathews S; Cole J; Ryono RA
Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
[TBL] [Abstract][Full Text] [Related]
18. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
Garwood CL; Dumo P; Baringhaus SN; Laban KM
Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
[TBL] [Abstract][Full Text] [Related]
19. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
[TBL] [Abstract][Full Text] [Related]
20. Low-dose vitamin K to augment anticoagulation control.
Reese AM; Farnett LE; Lyons RM; Patel B; Morgan L; Bussey HI
Pharmacotherapy; 2005 Dec; 25(12):1746-51. PubMed ID: 16305294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]